These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 1168690)

  • 21. Complement fixation by rheumatoid factor.
    Tanimoto K; Cooper NR; Johnson JS; Vaughan JH
    J Clin Invest; 1975 Mar; 55(3):437-45. PubMed ID: 1078825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Humoral immunostimulation. III. Requirements for divalent antibody and cellular aggregation.
    Shearer WT; Parker CW
    J Immunol; 1975 Sep; 115(3):613-9. PubMed ID: 807644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lysis of tumor cells by antibody and complement. II. Lack of correlation between amount of C4 and C3 fixed and cell lysis.
    Ohanian SH; Borsos T
    J Immunol; 1975 Apr; 114(4):1292-5. PubMed ID: 163862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of lethal effect of human serum upon Leishmania donovani.
    Pearson RD; Steigbigel RT
    J Immunol; 1980 Nov; 125(5):2195-201. PubMed ID: 7430624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of immune haemolysis by a serum factor found in C3-deficient subjects.
    Kitamura H; Tsuboi M
    Immunology; 1989 Feb; 66(2):264-9. PubMed ID: 2925225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
    Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activated guinea-pig C3 and the immune adherence receptor (a complement receptor) on cell membranes.
    Okada H; Okada N
    Immunology; 1975 Jun; 28(6):1165-71. PubMed ID: 1169221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Consumption of classical complement components by heart subcellular membranes in vitro and in patients after acute myocardial infarction.
    Pinckard RN; Olson MS; Giclas PC; Terry R; Boyer JT; O'Rourke RA
    J Clin Invest; 1975 Sep; 56(3):740-50. PubMed ID: 808560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neutralization of vesicular stomatitis virus (VSV) by human complement requires a natural IgM antibody present in human serum.
    Beebe DP; Cooper NR
    J Immunol; 1981 Apr; 126(4):1562-8. PubMed ID: 6259260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complement activation in semisolid media: insolubilization of alternative pathway convertases in agar gels with C3 nephritic factor-containing sera.
    Arnaout MA; Davis AE; Rosen RS; Alper CA
    J Immunol; 1977 Oct; 119(4):1316-20. PubMed ID: 894039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The failure to show a necessary role for C3 in the in vitro antibody response.
    Waldmann H; Lachmann PJ
    Eur J Immunol; 1975 Feb; 5(2):185-93. PubMed ID: 1086222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complement-mediated serum cytotoxicity for Leishmania major amastigotes: killing by serum deficient in early components of the membrane attack complex.
    Hoover DL; Berger M; Hammer CH; Meltzer MS
    J Immunol; 1985 Jul; 135(1):570-4. PubMed ID: 3998474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative comparison of techniques used to measure complement-mediated cytotoxicity of nucleated cells.
    Detrick-Hooks B; Borsos T; Rapp HJ
    J Immunol; 1975 Jan; 114(1 Pt 2):287-90. PubMed ID: 1117130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolation and characterization of Guinea pig properidin.
    Nicholson A; Austen KF
    J Immunol; 1977 Jan; 118(1):103-8. PubMed ID: 830742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trypsin-activated complex of human factor B with cobra venom factor (CVF), cleaving C3 and C5 and generating a lytic factor for unsensitized guinea pig erythrocytes. I. Generation of the activated complex.
    Miyama A; Kato T; Horai S; Yokoo J; Kashiba S
    Biken J; 1975 Dec; 18(4):193-204. PubMed ID: 1218074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition.
    Ziccardi RJ
    J Immunol; 1986 May; 136(9):3378-83. PubMed ID: 3485688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for restriction of the ability of complement to lyse homologous erythrocytes.
    Houle JJ; Hoffmann EM
    J Immunol; 1984 Sep; 133(3):1444-52. PubMed ID: 6430999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of plicatic acid on human serum complement includes interference with C1 inhibitor function.
    Giclas PC
    J Immunol; 1982 Jul; 129(1):168-72. PubMed ID: 6979566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation of guinea pig macrophages bearing surface C4 by fluorescence-activated cell sorting: correlation between surface C4 antigen and C4 protein secretion.
    Auerbach HS; Lalande ME; Latt S; Colten HR
    J Immunol; 1983 Nov; 131(5):2420-6. PubMed ID: 6355294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of complement by Schistosoma mansoni schistosomula: killing of parasites by the alternative pathway and requirement of IgG for classical pathway activation.
    Santoro F; Lachmann PJ; Capron A; Capron M
    J Immunol; 1979 Oct; 123(4):1551-7. PubMed ID: 113459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.